Form 4: UL Solutions Director Acquires Deferred Stock Units

UL Solutions Inc. Director Elisabeth Torstad reported the acquisition of dividend equivalent rights on deferred restricted stock units, increasing her beneficial ownership.

Summary

• Elisabeth Torstad, a Director at UL Solutions Inc. (ULS), reported changes in her beneficial ownership of the company's securities.
• On December 8, 2025, Torstad acquired 8 dividend equivalent rights related to deferred restricted stock units (DRSUs). These rights vest proportionally with DRSUs that vested on May 1, 2025, and are expected to settle in Class A Common Stock.
• On the same date, she acquired an additional 4 dividend equivalent rights related to other DRSUs. These rights vest proportionally with DRSUs that will vest on the earlier of May 20, 2026, or the annual meeting date, and are also expected to settle in Class A Common Stock.
• Following these transactions, Torstad beneficially owns 4,954 deferred restricted stock units (including accrued dividend equivalent rights) from the first tranche and 2,801 deferred restricted stock units (including accrued dividend equivalent rights) from the second tranche.
• Each dividend equivalent right represents a contingent right to receive one share of UL Solutions' Class A Common Stock.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. This is a routine insider transaction disclosure. The acquisition of dividend equivalent rights is a positive for aligning director interests with shareholders, but it's not a direct purchase of shares and doesn't indicate new capital inflow or significant operational news.

Positives

• Director Torstad's increased beneficial ownership through dividend equivalent rights aligns her interests with shareholders.
• The accrual of dividend equivalent rights indicates a mechanism for long-term incentive and retention for directors.

Risks

• The value of the deferred restricted stock units and dividend equivalent rights is tied to the future performance of UL Solutions' Class A Common Stock.
• Settlement of the DRSUs and dividend equivalent rights is subject to the terms of the Issuer's Non-Employee Director Deferred Compensation Plan, which could have specific conditions or limitations.

Future Outlook

The deferred restricted stock units and associated dividend equivalent rights are expected to be settled in shares of UL Solutions' Class A Common Stock on a date selected by the reporting person or as otherwise provided by the company's Non-Employee Director Deferred Compensation Plan.

Industry Context

This filing is a standard insider transaction disclosure. Equity compensation, including restricted stock units and dividend equivalent rights, is a common practice in public companies to align the interests of directors and executives with shareholders and to provide long-term incentives.

Comparison to Industry Standards

• The use of deferred restricted stock units (DRSUs) and dividend equivalent rights is a common form of equity compensation for non-employee directors across various industries, including the business services and safety science sector where UL Solutions operates.
• This structure helps defer income and align long-term interests, consistent with best practices in corporate governance for director compensation.
• Specific comparable companies or projects are not detailed in the filing, but this compensation mechanism is widely adopted by companies of similar size and market capitalization.

Corporate Governance

Stakeholder Impact

• Shareholders: The accrual of dividend equivalent rights aligns director interests with shareholders, as the value is tied to the company's stock performance.
• Directors: Provides long-term equity compensation and incentives for continued service.

Next Steps

• Settlement of the deferred restricted stock units and associated dividend equivalent rights into Class A Common Stock, as per the Non-Employee Director Deferred Compensation Plan.
• Future vesting of the second tranche of deferred restricted stock units on the earlier of May 20, 2026, or the annual meeting following the grant date.

Key Dates

Recommendation

This Form 4 filing details a routine accrual of dividend equivalent rights on existing deferred restricted stock units for a director. It does not contain any new information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. It's a standard disclosure of insider equity compensation, which generally has a neutral impact on investment decisions.

Keywords

UL Solutions, ULS, Elisabeth Torstad, Form 4, Insider Transaction, Deferred Restricted Stock Units, DRSU, Dividend Equivalent Rights, Director Compensation, Equity Compensation, Beneficial Ownership